Sign inJoin waitlistJoin the waitlist

DW

David Wyatt

Family Medicine

Credentials: · ·

History

Family Medicine

Research

Phase 1 Renal Impairment Trial Results Supports Targeted Individualized Dosing of ELX-02 in Patients With Nephropathic Cystinosis
The Journal of Clinical Pharmacology · 2021 · 6 citations
A Phase 1, Open-Label, Randomized Study to Investigate the Pharmacokinetics and Safety of Multiple Doses of Intranasal Naloxone in Healthy Participants
Clinical and Translational Science · 2026 · Last of 5 authors
A phase 1, first-in-human, open label, single ascending dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of stabilized isoamyl nitrite nasal…
Journal of Pharmacology and Experimental Therapeutics · 2025 · Last of 16 authors

AH
Allen Heller
1 paper
Christopher Holstege
1 paper
JN
Jeffrey Nau
1 paper
JP
Jerry Punch
1 paper
LC
Leonidas Carayannopoulos
1 paper · 1 as a fellow
TH
Thomas Haverty
1 paper